BANK OF MONTREAL /CAN/ - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 16 filers reported holding INMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$1,0000.0%168
-41.9%
0.00%
Q4 2020$1,0002890.00%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Empery Asset Management, LP 61,741$58,0000.27%
AllSquare Wealth Management LLC 545$1,0000.00%
TWO SIGMA SECURITIES, LLC 17,979$17,0000.00%
Creative Planning 10,832$10,0000.00%
ROYAL BANK OF CANADA 250$00.00%
TCI Wealth Advisors, Inc. 125$00.00%
TWO SIGMA INVESTMENTS, LP 39,700$37,0000.00%
OSAIC HOLDINGS, INC. 1,185$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 13,905$13,0000.00%
View complete list of INMED PHARMACEUTICALS INC shareholders